Wednesday, Nov. 6, 2019
8 a.m. – 1 p.m.
The Society for Immunotherapy of Cancer and the World Immunotherapy Council (WIC) are dedicated to advancing cancer immunotherapy and, likewise, the future leaders of the field. This program will provide the opportunity for young scientists and future leaders from throughout the world to interact, fulfilling the World Immunotherapy Council’s mission to facilitate rapid development and global dissemination of cancer immunotherapies through scientific exchange.
The young investigators, each chosen for exemplary work in the field of cancer immunotherapy, will contribute insight and perspectives into present and future issues, challenges, and improvements as cancer immunotherapy is integrated into mainstream cancer treatment. This program and its participants will ultimately highlight worldwide initiatives in cancer immunotherapy and facilitate scientific exchange and networking between today’s and tomorrow’s leaders. Additionally, this forum will provide a unique opportunity to showcase the world’s young, talented scientists and provide an opportunity for knowledge exchange and networking for these selected representatives.
The target audience for this program consists of individuals from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals who wish to learn more about the future of cancer immunotherapy research across the globe.
- Samir Khleif, MD – Georgetown University
- Jose A. Lopez-Martin, MD, PhD – 12 de Octubre University Hospital & Research Institute
- Brad Nelson, PhD – BC Cancer – Deeley Research Centre
- Graham Pawelec, PhD – University of Tuebingen
- Barbara Seliger, MD, PhD – Martin Luther University Halle-Wittenberg
- Joe Yeong, PhD – Singapore General Hospital
Upon completion of this meeting, participants will be able to:
- Recognize ongoing cancer immunotherapy research across the globe
- Translate worldwide state-of-the-art cancer immunotherapy strategies into practice
- Identify the unique challenges and future issues as cancer immunotherapy is integrated into
mainstream cancer treatment modalities
The World Immunotherapy Council’s 3rd Yo
ung Investigator Symposium is supported in part by a grant from Bristol-Myers Squibb.